Frontlight ResearchEarly access
Trial site
University of California Los Angeles Medical Center
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Ovarian cancer2 trials
- Asthma1 trial
- Cervical cancer1 trial
- Down syndrome1 trial
- Duchenne muscular dystrophy1 trial
- Endometrial cancer1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Haemophilia1 trial
- Hearing loss1 trial
- Heart failure1 trial
- High blood pressure1 trial
- and 7 more
- Phase
- Phase 1/23 trials
- Phase 22 trials
- Phase 31 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Completed1 trial
- Lead sponsor
- Incyte Corporation2 trials
- Boston University1 trial
- Duke University1 trial
- Genmab1 trial
- Madrigal Pharmaceuticals, Inc.1 trial
- and 3 more
Running trials
Recruiting
Active, not recruiting
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial
Recruiting
Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH
Recruiting
Recruiting
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Recruiting
Recruiting
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer2 recruiting
- Cervical cancer1 recruiting
- Duchenne muscular dystrophy1 recruiting
- Endometrial cancer1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Hearing loss1 recruiting
- Liver cirrhosis1 recruiting
- Lung cancer1 recruiting
- Mesothelioma1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 19 Nov 2026